Amy D. Marshall

1.4k total citations · 1 hit paper
13 papers, 943 citations indexed

About

Amy D. Marshall is a scholar working on Molecular Biology, Oncology and Biochemistry. According to data from OpenAlex, Amy D. Marshall has authored 13 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Biochemistry. Recurrent topics in Amy D. Marshall's work include Epigenetics and DNA Methylation (6 papers), Amino Acid Enzymes and Metabolism (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Amy D. Marshall is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Amino Acid Enzymes and Metabolism (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Amy D. Marshall collaborates with scholars based in Australia, United States and Singapore. Amy D. Marshall's co-authors include Gerard C. Grosveld, John E.J. Rasko, Charles G. Bailey, Qian Wang, Jeff Holst, Annora Thoeng, Michelle van Geldermalsen, Rajini Nagarajah, Yongmei Feng and Sandra O’Toole and has published in prestigious journals such as Cancer Research, Oncogene and International Journal of Cancer.

In The Last Decade

Amy D. Marshall

13 papers receiving 938 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer

2015 478 citations Michelle van Geldermalsen, Qian Wang et al. Oncogene profile →

Peers

Countries citing papers authored by Amy D. Marshall

Since Specialization

Citations

This map shows the geographic impact of Amy D. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy D. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy D. Marshall more than expected).

Fields of papers citing papers by Amy D. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy D. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy D. Marshall. The network helps show where Amy D. Marshall may publish in the future.

Co-authorship network of co-authors of Amy D. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Amy D. Marshall. A scholar is included among the top collaborators of Amy D. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy D. Marshall. Amy D. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Ctcf haploinsufficiency mediates intron retention in a tissue-specific manner 2020 ·RNA Biology ·(unknown), Ulf Schmitz, Amy D. Marshall, Darya Vanichkina, Rajini Nagarajah, (unknown), Justin Wong, Charles G. Bailey, John E.J. Rasko	11
2	CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic 2017 ·Oncogene ·Amy D. Marshall, Charles G. Bailey, (unknown), (unknown), (unknown), Cynthia Metierre, Yongmei Feng, Annora Thoeng, Anthony Richards, Ulf Schmitz, Maté Biro, Reyka G. Jayasinghe, Li Ding, Lyndal Anderson, Elaine R. Mardis, John E.J. Rasko	46
3	ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma 2017 ·Oncogenesis ·Amy D. Marshall, Michelle van Geldermalsen, Nicholas Otte, (unknown), (unknown), Annora Thoeng, Angel Pang, Rajini Nagarajah, (unknown), Qian Wang, Lyndal Anderson, John E.J. Rasko, Jeff Holst	63
4	LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma 2016 ·International Journal of Cancer ·Amy D. Marshall, Michelle van Geldermalsen, Nicholas Otte, Lyndal Anderson, Trina Lum, (unknown), (unknown), Annora Thoeng, Qian Wang, John E.J. Rasko, Jeff Holst	38
5	ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer breakdown → 2015 ·Oncogene ·Michelle van Geldermalsen, Qian Wang, Rajini Nagarajah, Amy D. Marshall, Annora Thoeng, Dadi Gao, William Ritchie, Yongmei Feng, Charles G. Bailey, Niantao Deng, Kate Harvey, Jane Beith, Christina Selinger, Sandra O’Toole, John E.J. Rasko, Jeff Holst	478
6	PAX3-FOXO1 Induces Up-Regulation of Noxa Sensitizing Alveolar Rhabdomyosarcoma Cells to Apoptosis 2013 ·Neoplasia ·Amy D. Marshall, (unknown), Ramon I. Klein Geltink, Gerard C. Grosveld	23
7	CTCF and BORIS in genome regulation and cancer 2013 ·Current Opinion in Genetics & Development ·Amy D. Marshall, Charles G. Bailey, John E.J. Rasko	44
8	The cancer‐testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells 2013 ·International Journal of Cancer ·Jessamy Tiffen, Charles G. Bailey, Amy D. Marshall, Cynthia Metierre, Feng Yue, Qian Wang, (unknown), Jeff Holst, John E.J. Rasko	40
9	Alveolar rhabdomyosarcoma – The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis 2012 ·Skeletal Muscle ·Amy D. Marshall, Gerard C. Grosveld	71
10	PAX3-FOXO1 Induces Cannabinoid Receptor 1 to Enhance Cell Invasion and Metastasis 2011 ·Cancer Research ·Amy D. Marshall, Irina V. Lagutina, Gerard C. Grosveld	43
11	PAX3‐FOXO1 and FGFR4 in alveolar rhabdomyosarcoma 2011 ·Molecular Carcinogenesis ·Amy D. Marshall, Martijn A. van der Ent, Gerard C. Grosveld	15
12	Depth of myometrial invasion to predict lymph node metastases in women with endometrial cancer 2011 ·Gynecologic Oncology ·(unknown), Andrew P. Soisson, Mark K. Dodson, (unknown), J. Hunn, Heather M. Moore, Karen Zempolich, David K. Gaffney, William T. Sause, (unknown), Kerry Rowe, (unknown), (unknown), Tom Belnap, (unknown), Amy D. Marshall	1
13	Mighty is a novel promyogenic factor in skeletal myogenesis 2008 ·Experimental Cell Research ·Amy D. Marshall, Mônica Senna Salerno, Mark Thomas, (unknown), Carole Berry, Kelly A. Dyer, (unknown), Trevor Watson, Marie Dziadek, Ravi Kambadur, (unknown), Mridula Sharma	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact